Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Nov;58(3):367–372.

Mazindol anorexia is mediated by activation of dopaminergic mechanisms.

Z L Kruk, M R Zarrindast
PMCID: PMC1667599  PMID: 990591

Abstract

1 Anorexia in rats following injections of mazindol (0.1-8 mg/kg i.p.) could be antagonized by pretreatment with a dopamine receptor blocker (primozide) but not by pretreatment with an alpha-adrenoceptor blocker (phenoxybenzamine), a beta-adrenoceptor blocker ((-)-propranolol), or a 5-hydroxytryptamine receptor blocker (methergoline). 2 In rats with a unilateral lesion in the substantia nigra made by stereotaxic injection of 6-hydroxydopamine, mazindol caused a dose-dependent turning towards the lesioned side, indicating an indirect mechanism of action. This effect could be antagonized by pretreatment with a dopamine receptor blocker. 3 In rats pretreated with reserpine and alpha-methyl-p-tyrosine, mazindol did not have any motor stimulant action. 4 In vitro studies with synaptosomes prepared from rat brain, indicated that mazindol blocks uptake and causes release of dopamine. 5 It is concluded that the anorectic action of mazindol is mediated by a dopaminergic mechanism.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Butcher S. G., Corrodi H., Fuxe K., Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970;11(3):303–314. doi: 10.1016/0014-2999(70)90006-3. [DOI] [PubMed] [Google Scholar]
  2. Andén N. E., Rubenson A., Fuxe K., Hökfelt T. Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol. 1967 Sep;19(9):627–629. doi: 10.1111/j.2042-7158.1967.tb09604.x. [DOI] [PubMed] [Google Scholar]
  3. Barzaghi F., Groppetti A., Mantegazza P., Müller E. E. Letter: Reduction of food intake by apomorphine: a pimozide-sensitive effect. J Pharm Pharmacol. 1973 Nov;25(11):909–911. doi: 10.1111/j.2042-7158.1973.tb09973.x. [DOI] [PubMed] [Google Scholar]
  4. Beretta C., Ferrini R., Glässer A. H. 1-Methyl-8-beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature. 1965 Jul 24;207(995):421–422. doi: 10.1038/207421a0. [DOI] [PubMed] [Google Scholar]
  5. Booth D. A. Mechanism of action of norepinephrine in eliciting an eating response on injection into the rat hypothalamus. J Pharmacol Exp Ther. 1968 Apr;160(2):336–348. [PubMed] [Google Scholar]
  6. Broekkamp C., van Rossum J. M. Clonidine induced intrahypothalamic stimulation of eating in rats. Psychopharmacologia. 1972;25(2):162–168. doi: 10.1007/BF00423193. [DOI] [PubMed] [Google Scholar]
  7. Carruba M. O., Groppetti A., Mantegazza P., Vicentini L., Zambotti F. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate. Br J Pharmacol. 1976 Apr;56(4):431–436. doi: 10.1111/j.1476-5381.1976.tb07454.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clineschmidt B. V., Mcguffin J. C., Werner A. B. Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine. Eur J Pharmacol. 1974 Aug;27(3):313–323. doi: 10.1016/0014-2999(74)90006-5. [DOI] [PubMed] [Google Scholar]
  9. Engstrom R. G., Kelly L. A., Gogerty J. H. The effects of 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine. Arch Int Pharmacodyn Ther. 1975 Apr;214(2):308–321. [PubMed] [Google Scholar]
  10. Ferris R. M., Tang F. L., Maxwell R. A. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J Pharmacol Exp Ther. 1972 Jun;181(3):407–416. [PubMed] [Google Scholar]
  11. Gogerty J. H., Penberthy C., Iorio L. C., Trapold J. H. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol). Arch Int Pharmacodyn Ther. 1975 Apr;214(2):285–307. [PubMed] [Google Scholar]
  12. Kruk Z. L. Dopamine and 5-hydroxytryptamine inhibit feeding in rats. Nat New Biol. 1973 Nov 14;246(150):52–53. doi: 10.1038/newbio246052a0. [DOI] [PubMed] [Google Scholar]
  13. Snyder S. H., Coyle J. T. Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther. 1969 Jan;165(1):78–86. [PubMed] [Google Scholar]
  14. Zambotti F., Carruba M. O., Barzaghi F., Vicentini L., Groppetti A., Mantegazza P. Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol. Eur J Pharmacol. 1976 Apr;36(2):405–412. doi: 10.1016/0014-2999(76)90094-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES